Abstract Subjects at risk of dementia benefit from participation in mentally stimulating activities, but no prior studies have investigated similar associations in Parkinson disease (PD). The aim of this study was to investigate the relationship between times spent engaging in mentally stimulating activities and cognitive functions in PD while accounting for the degree of primary neurodegenerations. PD patients (N = 41, 33 males; age 68.5 ± 7.2; Hoehn and Yahr stage 2.6 ± 0.6) completed the Community Health Activities Model Program for Seniors questionnaire, minimental state examination (MMSE), and [
Introduction
There is accumulating evidence that frequent engagement in mentally stimulating activities is beneficial to brain health for subjects at risk of mild cognitive impairment (Geda et al. 2011; Verghese et al. 2006) or dementia (Verghese et al. 2003) . To our knowledge, no prior studies have investigated similar associations involving & Nicolaas I. Bohnen nbohnen@umich.edu engagement in mentally stimulating activities in Parkinson disease (PD) patients. It is possible that a higher degree of participation in mentally stimulating activities may simply reflect lower biological disease severity rather than mental stimulation exerting an intrinsic beneficial effect on the brain. This issue can, at least partially, be addressed by conducting studies that utilize biomarkers of biological disease severity, such as in vivo PET imaging assessments of biological substrates of disease severity and cognitive impairment.
The aim of this study was to investigate the relationship between time spent engaging in mentally stimulating activities and cognitive performance scores while accounting for the degree of primary PD-related neurodegenerations. We hypothesized that more time participating in mentally stimulating activities is associated with less severe cognitive symptoms, independent of the degree of nigrostriatal dopaminergic and cortical cholinergic denervations as assessed by in vivo PET.
Subjects and methods

Subjects and clinical test battery
This cross-sectional study involved 41 PD subjects (33 males, 8 females), mean age 68.5 ± 7.2 years (range 56-84), and mean duration of disease of 8.1 ± 3.9 years (2.5-20) , who participated in an imaging biomarker study of mobility impairments in PD and who completed the Community Health Activities Model Program for Seniors questionnaire (CHAMPS) and Mini-Mental State Examination (MMSE) (Folstein et al. 1975 ) at time of study enrollment and imaging procedures. Subjects met the UK PD Society Brain Bank clinical diagnostic criteria. None of the subjects had evidence of dementia as defined by cognitive impairment and impaired instrumental activities of daily living. Abnormal striatal dopaminergic ([ 11 C]DTBZ) PET findings were consistent with the diagnosis of PD in all subjects. No subjects had a history of a large artery stroke or other significant intracranial disease. Most subjects had moderate severity of disease: one patient in modified Hoehn and Yahr (HY) stage 1, 1 in stage 1.5, 6 in stage 2, 19 in stage 2.5, 12 in stage 3, 1 in stage 4, and 1 in stage 5. The mean HY stage was 2.6 ± 0.6. The mean UPDRS motor score was 30.0 ± 10.6 (range 7-53) (Fahn and Elton 1987) . All PD subjects were treated with dopaminergic agents; 28 subjects were taking a combination of dopamine agonist and carbidopa-levodopa medications, of whom 12 were using carbidopa-levodopa alone, and one was taking a dopamine agonist alone. Mean levodopa equivalent dose (LED) was 962.5 ± 521.3 mg (Tomlinson et al. 2010) . Subjects on dopaminergic drugs were examined in the morning after withholding dopaminergic drugs overnight.
The CHAMPS activity questionnaire has items that assess physical activity and also items that assess engagement in mentally stimulating activities (Stewart et al. 2001 ). To develop a rating scale of the subset of the CHAMPS questions assessing levels of engagement in mentally stimulating activities (i.e., items 1-6, 8, 11-13, and 17-18) , a factor analysis was performed from a larger CHAMPS questionnaire database at our center. We had data available from a total of 48 subjects with PD (39 males, 9 females; mean age 68.8 ± 7.3 years (range 56-84) and mean HY stage 2.7 ± 0.6 (range 1-5); note that 41 of these PD subjects who had completed additional dopaminergic and cholinergic brain PET imaging are the source of the primary data analysis in this study, and 13 normal elderly subjects (6 males, 7 females; mean age 70.3 ± 9.5 years (range 55-84). The factor analysis showed the presence of a single factor with an eigenvalue[2 (k = 2.7). 9 out of 12 items had high loading weights ([0.35) : items 1-6, 8, 11, and 18. The Cronbach a was 0.68, which is in the working range for internal consistency of the scale as high ([0.9) or low values (like \0.5) should be avoided (Tavakol and Dennick 2011) . Consequently, the nine high loading items were summed and used as the primary outcome variable in our analysis. The new rating scale included activities such as volunteering, visiting friends, computer use, crafts, attending church or reading yielding a total duration of these mentally stimulating activities over a timespan of 4 weeks as the primary outcome measure. Findings of engagement in physical activity and motor performance from this cohort of patients have been previously reported (Snider et al. 2015) .
The study was approved by the Institutional Review Boards of the University of Michigan and VA Ann Arbor Health Care System. Written informed consent was obtained from all subjects prior to any research procedures.
Imaging techniques
All subjects underwent brain MRI and [
11 C]PMP acetylcholinesterase (AChE) and [
11 C]DTBZ vesicular monoamine transporter type 2 (VMAT2) PET. [
11 C]DTBZ PET imaging was performed in the morning after withholding dopaminergic medications overnight. After completing the [ 11 C]DTBZ PET scan, subjects on dopaminergic medications took their medications and proceeded with the [ 11 C]PMP PET. MRI was performed on a 3 Tesla Philips Achieva system (Philips, Best, The Netherlands) and PET imaging was performed in 3D imaging mode with an ECAT Exact HR? tomograph (Siemens Molecular Imaging, Inc., Knoxville, TN, USA) (Bohnen et al. 2012) . The imaging studies were generally completed within 1-2 days of the clinical and neuropsychological testing sessions. 11 C]PMP were prepared as described previously (Shao et al. 2011) . Dynamic PET scanning was performed for 70 min using a bolus dose of 15 mCi [ 11 C]PMP dose. A bolus/infusion protocol was used for [ 11 C]DTBZ (15 mCi) in 60 min (Koeppe et al. 1999) .
Analysis
All image frames were spatially coregistered within subjects with a rigid-body transformation to reduce the effects of subject motion during the imaging session (Minoshima et al. 1993) . Interactive Data Language image analysis software (Harris Geospatial Solutions, Broomfield, CO, USA) was used to manually trace volumes of interest (VOI) on MRI images to include the caudate nucleus and putamen of each hemisphere. VOIs were bilaterally averaged. Total neocortical VOI were defined using semi-automated threshold delineation of the cortical gray matter signal on the MRI scan (Bohnen et al. 2012) .
[ 11 C]DTBZ distribution volume ratios (DVR) were estimated using the Logan plot graphical analysis method with the striatal time activity curves as the input function and the total neocortex as reference tissue (a region low in VMAT2 binding sites), with the assumption that the nondisplaceable distribution is uniform across the brain at equilibrium (Koeppe et al. 1999) .
AChE [ 11 C]PMP hydrolysis rates (k 3 ) were estimated using the striatal volume of interest (defined by manual tracing on the MRI scan of the putamen and caudate nucleus) as the reference tissue for the integral of the precursor delivery (Nagatsuka et al. 2001) . AChE assessment has been recognized as a reliable marker for cholinergic pathways in the human brain (Selden et al. 1998; Shute and Lewis 1966) . AChE PET imaging assesses cholinergic terminal integrity with cortical uptake reflecting basal forebrain neuron integrity.
Multiple regression analysis was performed to determine the relationship between engagement in mentally stimulating activities and MMSE scores while controlling for nigrostriatal VMAT2 DVR, cortical AChE hydrolysis rate (k 3 ), HY motor disease stage, age, education, and duration of disease covariates in the PD subjects. The CHAMPS activity questionnaire total time spent in physical activity and UPDRS motor scores were also used as covariates for post hoc confounder analysis (Stewart et al. 2001) . Analyses were performed using SAS version 9.3 (SAS Institute, Cary, NC, USA).
Results Table 1 provides a summary of the clinical, cognitive, duration of mentally stimulating activities, and PET imaging findings.
Multivariate regression analysis to account for possible confounders
Multiple regression analysis using the MMSE score as the outcome variable demonstrated a significant overall model [total model: F (6,34) = 3.8, p = 0.005] with significant regressor effect for the duration of participation in mentally stimulating activities (standardized b = 0.39, t = 2.8, p = 0.009) while accounting for effects of caudate nucleus dopaminergic activity (b = -0.07, t = -0.5, p = 0.6), cortical cholinergic activity (b = 0.35, t = 2.4, p = 0.024), education (b = -0.07, t = -0.5, p = 0.6), age (b = -0.2, t = -1.6, p = 0.11), and duration of disease (b = 0.21, t = 1.5, p = 0.14; Table 2 ; Fig. 1 ).
Scatter plots of the (non-significant) relationships between caudate nucleus VMAT2 (R = 0.24, p = 0.14) and cortical AChE (R = 0.24, p = 0.13) activities and duration of participation in mentally stimulating activities are shown in Figs. 2 and 3, respectively.
Exploratory post hoc analysis: accounting for effects of physical activity or parkinsonian motor impairments An exploratory post hoc analysis was performed to account for physical activity levels that potentially may be associated with behavioral patterns associated with engagement in mentally stimulating activities. For this purpose, the CHAMPS physical activity score [as time spent in physical activity in hours per 4 weeks (Snider et al. 2015) ] was entered as an additional regressor in the model. Multiple regression analysis using the MMSE score as the outcome variable demonstrated a significant overall model (F (7,33) = 4.4, p = 0.0016) with significant regressor effect for the duration of weekly participation in mentally stimulating activities (standardized b = 0.31, t = 2.1, p = 0.04) while accounting for effects of caudate nucleus dopaminergic activity (b = -0.04, t = -0.31, p = 0.76), cortical cholinergic activity (b = 0.36, t = 2.6, p = 0.014), HY stage (b = -0.28, t = -2.0, p = 0.058), age (b = -0.11, t = -0.8, p = 0.42), duration of disease (b = 0.27, t = 2.0, p = 0.056), and 4-week duration of physical activity (b = 0.13, t = 0.9, p = 0.39).
A similar post hoc regression analysis entering the UPDRS motor severity score in the model confirmed the significant regressor effect for time spent in mentally stimulating activities (standardized b = 0.31, t = 2.2, p = 0.033; F (6,36) = 4.0, p = 0.0036) independent from cortical cholinergic activity (b = 0.30, t = 2.1, p = 0.041), UPDRS motor scores (b = -0.28, t = -1.8, p = 0.082), and the other variables. 
Discussion
Our findings show that more frequent engagement in mentally stimulating activities is associated with better cognitive performance scores independent of primary dopaminergic and cholinergic neurodegenations in PD. Our results add to a growing body of the literature indicating that engagement in mental stimulation is related to preservation of cognitive performance. Among elderly adults, mentally stimulating activities have been associated with a reduced risk of mild cognitive impairment (Geda et al. 2011; Verghese et al. 2006 ) and dementia (Verghese et al. 2003) . Our data provide additional support for the possibility that engagement in mentally stimulating activities may preserve cognitive performance, even among patients with PD. Several mechanisms have been proposed that may promote neuroplasticity and may provide a possible explanation for this finding. Mental stimulation may promote cerebral blood flow (Silvestrini et al. 1994) , which has been found to activate neurotrophic functions, synaptogenesis, and neurogenesis [see for review: (Paillard et al. 2015) ]. Existing neural networks may also be reinforced, buffering against cognitive decline (La Rue 2010). Furthermore, frequent engagement in mentally stimulating activities may be indicative of an overall healthy lifestyle (Geda et al. 2011) . In this case, the benefits of a healthy lifestyle may extend to preservation of brain function. However, our analysis was adjusted for time spent in physical activity (Snider et al. 2015) , suggesting an intrinsic benefit of mentally stimulating activities on cognition in PD.
Many of the activities selected to operationalize mental stimulation involved social interaction. Activities such as volunteering, visiting friends, attending concerts or church may all involve some degree of social interaction. Therefore, it is feasible that social interaction may also play a role in the preservation of cognitive performance. Geda et al. (2011) reported that some social activities, such as traveling and going out with friends, were associated with decreased risk of mild cognitive impairment. Further research is necessary to clarify the role that social interaction plays in the preservation of cognitive capabilities. Higher degree of engagement in mentally stimulating activities may reflect lifetime activities. However, our findings were independent from the level of education.
Cortical cholinergic denervation is a major neurodegeneration associated with progressive declines across the spectrum of cognitive impairment in PD and typically occurs in the context of significant caudate nucleus dopaminergic denervation (Bohnen et al. 2015) . Our findings confirm that cortical cholinergic activity is an important determinant of cognition in PD and that more engagement in mentally stimulating activities may have incremental effects.
One potential limitation of the study is that the crosssectional study design and lack of prospective assessment does not provide etiological information regarding whether engagement in mentally stimulating activities may lower the risk of dementia. Given that only a correlational relationship has been indicated, it is also possible that there is not a direct causality but a reverse causality. In this case, a lack of engagement in mentally stimulating activities may be a symptom of cognitive decline, rather than a risk factor. If this were the case, we would expect to observe more severe dopaminergic or cholinergic degenerations in subjects reporting lower levels of engagement in mentally stimulating activities. However, our findings remained statistically significant when controlling for possible confounding effects involving differences in dopaminergic and cholinergic neurobiology as well as motor severity of disease among the study participants. Therefore, these results are not consistent with the explanation that level of engagement in mentally stimulating activities is a function of disease severity, indicating that engagement in mentally stimulating activities may have an intrinsic beneficial effect on the brain. A different bias may be the fact that subjects with more frequent engagement with mentally or mentally stimulating activity also engage more with physical activity and exercise. However, our analysis was adjusted for duration of participation with physical activity suggesting an independent effect. Furthermore, our findings were independent from PD motor disease severity and parkinsonian motor scores.
The association between duration of time spent in mentally stimulating activities and cognitive performance may be mediated by other factors, such as education, time spent in physical activities, or socio-economic status. For this reason, we have adjusted our analysis for the effects of education and time spent in physical activities (Snider et al. 2015) . Our main study population was a veteran population, which may reflect a more homogeneous cross section of PD patients and who may have a comparable socioeconomic status and lifestyle interests in common.
There are several limitations to this study, including the use of the MMSE as the cognitive outcome scale. For example, the MMSE has been shown to be less sensitive to detect executive cognitive function deficits in PD compared to other scales, like the Montreal Cognitive Assessment (Chou et al. 2014) . Our patient population was predominantly male and, therefore, not adequately powered to asses for possible gender effects. Another limitation of this study is its reliance on data obtained from a self-reported activity questionnaire. Subjective reporting of self-assessed activity engagement through questionnaires may be biased and overestimate (or underestimate) the amount of time spent in certain activities to be viewed as more (or less) desirable by the respondent. As this study does not allow for independent measuring of the accuracy of self-reported engagement in mentally stimulating activities, one direction for future research could be more objective measurement or monitoring of mental activity engagements.
Another consideration is that the survey questions themselves, particularly those involving engagement in mentally stimulating activities, may not encompass that the full range of activities subjects may participate in during the span of several weeks and future studies may aim to sample a wider breadth of cognitive or social activities.
Our study is based on a within-group analysis of subjects with PD. We did not compare findings to a non-PD control group. Therefore, we cannot make any inferences about disease-specific findings in our study.
We conclude that engagement in mentally stimulating activities is associated with better cognitive abilities in PD independent of nigrostriatal dopaminergic and cortical cholinergic degenerations, education, level of physical activity, or severity of motor disease. Findings suggest that participation in mentally stimulating activities may help to promote cognitive preservation in PD. Future research involving longitudinal studies are needed to investigate whether more frequent engagement in mentally stimulating activities may lower risk of conversion to dementia in PD, which may provide a framework for new cognitive training therapies in PD (Dodge et al. 2015) .
